最新ニュース Amer Sports (NYSE:AS) 株価情報

Amer Sports

Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.

Amer Sports Inc

ASA Gold And Precious Metals Ltd

AT & S AUSTRIA TECH & SYS by AT&S Austria Technologie & SystemTechnik AG Leoben

AT&S Austria Technologie & Systemtechnik AG

AUSTRALIAN AGRICULTURAL by Australian Agricultural Co Ltd.

Australian Agricultural Co Ltd

Sendas Distribuidora SA ADR (Sponsored)

SENDAS DISTRIBUDRA S/ADR by Sendas Distribuidora S.A.

Sendas Distribuidora SA

American Salars Lithium Inc

ASSURANCEAMERICA by AssuranceAmerica Corp.

Asana Inc

Waitr Holdings Inc

Aurora Spine Corp

WAITR HOLDINGS INC by Waitr Holdings Inc.

ASIA STANDARD INTL GP ORD by Asia Standard International Group Ltd.

Asia Standard International Group Ltd

Asi Aviation Inc

Assa Abloy AB

Associated Banc-Corp

Associated Banc-Corp 6.625% Fixed-Rate Reset Subordinated Notes due 2033

ASSOCIATED BRIT FOOD ORD by Associated British Foods plc

Associated British Foods PLC

ASSOCIATED BRI/F UNSP/ADR by Associated British Foods plc

ASAHI GROUP HLDGS U/ADR by Asahi Group Holdings Ltd.

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Holdings Inc

Aspire Biopharma Holdings, Inc. - Warrant

ASAHI GROUP HOLDINGS ORD by Asahi Group Holdings Ltd.

Asahi Group Holdings Ltd

Associated Banc-Corp Depositary Shares, each representing a 1/40th interest in a share of 5.875% Non-Cumulative Perpetual Preferred Stock, Series E

Associated Banc-Corp Depositary Shares, each representing a 1/40th interest in a share of Associated Banc-Corp 5.625% Non-Cumulative Perpetual Preferred Stock, Series F

Ardmore Shipping Corporation Common Stock

Ardmore Shipping Corp

A SPAC I ACQUISITION CORP USD CL A ORD SHS

A SPAC I ACQUISITION CORP USD RTS

A SPAC I ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH OF NO PAR VALUE & ONE

A SPAC I ACQUISITION CORP WT EXP

A SPAC II ACQUISITION CORP CL A

A SPAC II ACQ CORP by A SPAC II Acquisition Corp.

A SPAC II Acquisition Corp

ASCENDIA BRANDS INC by Ascendia Brands, Inc.

A SPAC II ACQUISITION CORP RT

A SPAC II ACQUISITION CORP UNIT 1 CL A& 1/2 WT EXP & 1 RT

A SPAC II ACQUISITION CORP WT EXP

ARISTOCRAT GRP CORP by Aristocrat Group Corp

Aristocrat Group Corp

ASICS Corp

ACOTEC SCIENTIFIC HLD ORD by ACOTEC SCIENTIFIC HLDGS LTD

Acotec Scientific Holdings Ltd

AMSC ASA

Auscrete Corp

ASCLETIS PHARMA INC by Ascletis Pharma Inc.

Ascletis Pharma Inc

Absecon Bancorp

ASCOPIAVE SPA TREVISO ORD by Ascopiave SPA Treviso

Ascopiave SpA

AMER CRYSTAL SUGAR PFD by American Crystal Sugar Co.

American Crystal Sugar Co

ARIZONA SONORAN COPPER CO by Arizona Sonoran Copper Company Inc.

Arizona Sonoran Copper Co Inc

A SPAC II Acquisition Corp Warrants (15/10/2026)

Astro Aerospace Ltd

ASCENDANT RES INC ORD by Ascendant Resources Inc.

Ascendant Resources Inc

ARCTIC STAR EXPL CORP by Arctic Star Exploration Corp.

Arctic Star Exploration Corp

Global X FTSE Southeast Asia ETF

APT SATELLITE HOLDINGS by APT Satellite Holdings Ltd.

APT Satellite Holdings Ltd

AISIN SEIKI CO LTD ORD by Aisin Corporation

Aisin Corp

FlexShares Real Assets Allocation Index Fund

ASIAFIN HLDGS CORP by ASIAFIN HOLDINGS CORP.

Asiafin Holdings Corp

ASFG INC by ASFG, Inc.

APPSOFT TECHNOLOGIES INC by AppSoft Technologies, Inc.

AppSoft Technologies Inc

AMERICAN SCIENTFC RES by American Scientific Resources, Inc.

American Scientific Resources Inc

Associates First Capital Corp

Liberty All Star Growth Fund Inc

abrdn Global Infrastructure Income Fund Common Shares of Beneficial Interest

abrdn Global Infrastructure Income Fund

AGC Inc

ASGN Inc

Asante Gold Corp

ASTRALIS A/S by Astralis A/S

Altri SGPS SA

Altus Group Ltd

ASIA GLOBAL CROSSING A by Asia Global Crossing Ltd.

Asia Global Crossing Ltd

Ashland Inc

Ashtrom Group Ltd

ASBERRY 22 HLDGS INC by ASBERRY 22 HLDGS INC.

Asberry 22 Holdings Inc

ASHLEY SVCS GROUP LTD by ASHLEY SVCS GROUP LTD.

Ashley Services Group Ltd

Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF

Ashtead Group PLC

ASHTED GRP PLC UNSP/ADR by Ashtead Group PLC

DBX ETF Trust Xtrackers MSCI China A Inclusion Equity ETF

PROGRESSIVE PLANET NEW by Progressive Planet Solutions Inc.

Progressive Planet Solutions Inc

Matthews International Funds Matthews Pacific Tiger Active ETF

ACCREDITED SOLUTIONS INC by Accredited Solutions Inc.

Accredited Solutions Inc

AdvanSix Inc

Permission Coin

ALASKA PACIFIC ENERGY by Alaska Pacific Energy Corp.

Alaska Pacific Energy Corp

ASTIKA HOLDINGS INC by Astika Holdings, Inc.

Astika Holdings Inc

ASKUL Corp

ASKA PHARM HLDGS CO LTD by ASKA PHARMACEUTICAL HLDGS CO LTD

ASKA Pharmaceutical Holdings Co Ltd

AerSale Corp

ASL MARINE HLDGS LTD by ASL Marine Holdings Ltd.

ASL Marine Holdings Ltd

ABRDN EUROPEAN LOGISTICS by ABRDN EUROPEAN LOGISTICS INCOME PLC

AMER SILVER MINING CO by American Silver Mining Co.

American Silver Mining Co

News

Intchains Group Announced It Has Entered Into A Securities Purchase Agreement With An Institutional Investor For A Registered Direct Offering Of 361,011 Of Its American Depositary Shares, Each ADS Representing Two Class A Ordinary Shares Of The Company At $2.77 Per ADS

For the fiscal full year 2026, SailPoint expects:
<ul>
<li>Total ARR: In the range of $1,075 to $1,085 million, representing 23% to 24% year-over-year growth.</li>
<li>Total Revenue: In the range of $1,025 to $1,035 million, representing 19% to 20% year-over-year growth.</li>
<li>Adjusted Income from Operations: In the range of $151 to $156 million, representing adjusted operating margin of 14.6% to 15.2%.</li>
<li>Adjusted EPS: In the range of $0.14 to $0.18 per diluted share.</li>
</ul>

Guidance

SAIL

SailPoint Expects FY25 Revenue Of $1.025B-$1.035B Vs $1.023B Est, Adjusted EPS Of $0.14-$0.18 Vs $0.13 Est

Contracts

Gasboy, A Vontier Company Announced That It Has Secured A Coveted Sourcewell Contract Alongside Vontier Portfolio Partners Angi, Teletrac Navman, Veeder-root And Konect

LSPD

Lightspeed  Sees Gross Profit CAGR Of ~20-25% And Customer Location CAGR Of ~10-15% In Its Two Growth Engines - Retail In North America And Hospitality In Europe For The Next Three Years

On Tuesday, March 25, U.S. markets closed in green as investors reacted to mixed signals: Apple gained while Nvidia dipped, and attention turned to possible shifts in Trump&#8217;s trade policy.
Market uncertainty persists amid inflation worries, declining fiscal strength, and cautious Fed comments. The key focus now shifts to Friday&#8217;s release of the Fed&#8217;s preferred inflation gauge, the PCE index.
In economic data, Consumer confidence dipped to 92.9, missing expectations of 93.5. Home prices rose 4.7% in January, slightly below forecasts of 4.8% but higher than December&#8217;s 4.5%. New home sales climbed 1.8% to 676,000 in February, falling short of the 680,000 estimate, despite rebounding from January&#8217;s revised 6.9% drop, suggesting lingering housing market uncertainty.
Most S&amp;P 500 sectors rose, led by consumer discretionary, communication, and financial stocks, while utilities and health care declined.
The Dow Jones Industrial Average increased by 0.01% to 42,587.50, the S&amp;P 500 up 0.16% to 5,776.65, and the Nasdaq Composite rose 0.47% to 18,271.86.
Asia Markets Today
<ul>
<li>On Wednesday, Japan&#8217;s Nikkei 225 closed the session higher by 0.73% at 38,057.00, led by gains in the Power, Rubber and Chemical, Petroleum &amp; Plastic sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 was up 0.71% and closed at 7,999.00, led by gains in the A-REITs, Consumer Staples, and Industrials sectors.</li>
<li>India&#8217;s Nifty 50 fell 0.77% to 23,486.85, while Nifty 500 was down 0.76% at 21,275.45.</li>
<li>China&#8217;s Shanghai Composite declined 0.04% to 3,368.70, and the Shanghai Shenzhen CSI 300 rose   0.51% to 3,934.85.</li>
<li>Hong Kong&#8217;s Hang Seng was up 0.60%, ending the session at 23,483.32.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was down 0.96%.</li>
<li>Germany&#8217;s DAX declined 0.95%.</li>
<li>France&#8217;s CAC slid 0.92%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.03%.</li>
<li>European shares fell as healthcare stocks dragged the STOXX 600 lower despite gains in energy. Caution lingered over U.S. tariffs, though Europe remains attractive amid German stimulus hopes.       </li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.62% at $69.43/bbl, and Brent was up 0.62% at $72.84/bbl.</li>
<li>Oil prices rose slightly on tighter supply fears after a U.S. tariff threat on Venezuelan crude buyers and a surprise U.S. inventory drop, though gains were capped by easing tensions between Russia and Ukraine.</li>
<li>Natural Gas gained 0.39% to $3.982.</li>
<li>Gold was trading lower by 0.09% at $3,051.95, Silver was up 0.17% to $34.248, and Copper gained 1.27% to $5.2770.</li>
</ul>
U.S. Futures at 06:00 AM ET
<ul>
<li>Dow futures were down 0.15%, S&amp;P 500 futures declined 0.18% and Nasdaq 100 futures slid 0.24%.</li>
<li>U.S. stock futures dipped Wednesday as investors awaited clarity on Trump&#8217;s upcoming tariff measures, set for April 2.</li>
</ul>
Forex at 06:00 AM ET
The U.S. Dollar Index slid 0.01% to 104.20, USD/JPY was up 0.10% to 150.04, and USD/AUD declined 0.138% to 1.5804.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Down As Tariff Concerns Persist - Global Markets Today While US Slept

DLTR

Dollar Tree Sees Q1 Comparable Store Sales Growth Of 3% - 5%

Biotech

General

VKTX

Viking Therapeutics Completes Enrollment In Phase 2 VENTURE-Oral Dosing Trial Of VK2735 Tablet Formulation For Patients With Obesity

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.
Shares of Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) fell sharply in pre-market trading after the company reported quarterly <a href="https://in.benzinga.com/25/03/44476959/chewy-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">earnings</a>.
Chewy reported quarterly earnings of 28 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $3.25 billion which beat the analyst consensus estimate of $3.20 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Chewy shares declined 3.5% to $32.44 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares fell 22.1% to $2.24 in pre-market trading after the company priced its $50 million public offering of 25 million common stock at $2.00 per share.</li>
<li>Zhengye Biotechnology Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares tumbled 14.6% to $7.00 in pre-market trading after gaining 41% on Tuesday.</li>
<li>Nyxoah S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) fell 11.8% to $9.99 in today's pre-market trading. The FDA issued Nyxoah an approvable letter for its Genio&#xAE; system.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) fell 9.5% to $9.10 in pre-market trading.</li>
<li>Oruka Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKA#NASDAQ">ORKA</a>) shares fell 5% to $11.40 in pre-market trading.</li>
<li>REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) fell 3.8% to $7.90 in pre-market trading.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) declined 3.5% to $9.70 in pre-market trading.</li>
<li>Perpetua Resources Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) fell 3% to $10.87 in pre-market trading.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) slipped 2.4% to $6.83 in pre-market trading. Bausch Health announced the pricing of upsized private offering of senior secured notes.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

CHWY

HUMA

NYXH

ORKA

PPTA

RAPP

RGNX

ZYBT

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Dollar Tree Sees Q1 Revenue Of $4.5B - $4.6B; Adj EPS Of $1.10 - $1.25

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) with a Buy and lowers the price target from $18 to $12.

Price Target

Analyst Ratings

CRMD

Needham Maintains Buy on Cormedix, Lowers Price Target to $12

Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.05 by 460 percent. This is a 55.56 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $3.25 billion which beat the analyst consensus estimate of $3.20 billion by 1.53 percent. This is a 14.75 percent increase over sales of $2.83 billion the same period last year.

Earnings

Chewy Q4 2024 Adj EPS $0.28 May Not Be Comparable To $0.05 Estimate, Sales $3.25B Beat $3.20B Estimate

RILY

B. Riley Financial Announced It Has Entered Into A Privately Negotiated Exchange Agreement With An Institutional Investor, Which Will Reduce The Company's Total Outstanding Debt By Approximately $35M

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Arvinas Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>)</h3>
<ul>
<li>On March 11, Arvinas announced topline results from the phase 3 VERITAC-2 Trial of Vepdegestrant Monotherapy versus Fulvestrant in adults with advanced or retastatic breast cancer. The company's stock fell around 53% over the past month and has a <a href="https://www.benzinga.com/quote/ARVN">52-week low of $7.91</a>.</li>
<li>RSI Value: 25.9</li>
<li>ARVN Price Action: Shares of Arvinas fell 5.6% to close at $8.13 on <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Tuesday</a>. </li>
</ul>
<h3 class="wp-block-heading">Simulations Plus Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>Simulations Plus will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3. The company's stock fell around 19% over the past month and <a href="https://www.benzinga.com/quote/SLP">has a 52-week low </a>of $24.00.</li>
<li>RSI Value: 29.7</li>
<li>SLP Price Action: Shares of Simulations Plus fell 3.2% to close at $24.72 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">SLP stock</a>. </li>
</ul>
<h3 class="wp-block-heading">Iovance Biotherapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>)</h3>
<ul>
<li>On March 21, Iovance Biotherapeutics reported inducement grants under NASDAQ listing rule 5635(c)(4). The company's stock fell around 35% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/IOVA">low of $3.42.</a></li>
<li>RSI Value: 26.7</li>
<li>IOVA Price Action: Shares of Iovance Biotherapeutics fell 4.1% to close at $3.48 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">IOVA shares</a>. </li>
</ul>
Learn more about BZ Edge Rankings—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">click to see scores for other stocks in the sector and see how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Long Ideas

ARVN

IOVA

Top 3 Health Care Stocks That Are Set To Fly This Month

Financial Outlook
For the first quarter of fiscal 2026, SailPoint expects:
<ul>
<li>Total ARR: In the range of $896 to $900 million, representing 26% to 27% year-over-year growth.</li>
<li>Total Revenue: In the range of $224 to $226 million, representing 19% to 20% year-over-year growth.</li>
<li>Adjusted Income from Operations: In the range of $14 to $15 million, representing adjusted operating margin of 6.2% to 6.7%.</li>
<li>Adjusted EPS: In the range of ($0.02) to $0.00 per diluted share.</li>
</ul>
For the fiscal full year 2026, SailPoint expects:
<ul>
<li>Total ARR: In the range of $1,075 to $1,085 million, representing 23% to 24% year-over-year growth.</li>
<li>Total Revenue: In the range of $1,025 to $1,035 million, representing 19% to 20% year-over-year growth.</li>
<li>Adjusted Income from Operations: In the range of $151 to $156 million, representing adjusted operating margin of 14.6% to 15.2%.</li>
<li>Adjusted EPS: In the range of $0.14 to $0.18 per diluted share.</li>
</ul>

SailPoint Expects Q1 Revenue Of $224M-$226M Vs $228.43M Est, Adjusted EPS Of $(0.02)-$0.00 Vs $(0.01) Est

GME: 14% &#x7C; <a href="https://www.benzinga.com//node/44481286">GameStop shares are trading higher following better-than-expected Q4 adjusted EPS results.</a>
&nbsp;
DLTR: 7% &#x7C; <a href="https://www.benzinga.com//node/44480520">Dollar Tree shares are trading lower after Truist Securities cut its price target on the stock from $83 to $76.</a>
&nbsp;
SURG: 114% &#x7C; <a href="https://www.benzinga.com//node/44481687">SurgePays shares are trading higher after the company reported better-than-expected FY24 sales results.</a>

Comments

Amer Sports

ニュース

最新ニュース Amer Sports (NYSE:AS) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル